{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:01:32Z","timestamp":1771707692423,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochirurgie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neuchi.2015.10.006","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:31:27Z","timestamp":1453941087000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neurofibromatosis type 2 service delivery in England"],"prefix":"10.1016","volume":"64","author":[{"given":"S.K.","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.G.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuchi.2015.10.006_bib0075","first-page":"727","article-title":"Mosaicism in classical neurofibromatosis type 2: a common mechanism for sporadic disease in tumor prone syndromes?","volume":"63","author":"Evans","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neuchi.2015.10.006_bib0080","first-page":"91","article-title":"Neurofibromatosis type 2","volume":"70","author":"Evans","year":"2011","journal-title":"Adv Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.neuchi.2015.10.006_bib0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: a consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Brit J Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2015.10.006_bib0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S002221510012328X","article-title":"Type 2 neurofibromatosis: the need for supraregional care","volume":"107","author":"Evans","year":"1993","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.neuchi.2015.10.006_bib0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumour prone syndromes: estimates from a UK genetic family register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.neuchi.2015.10.006_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neuchi.2015.10.006_bib0105","article-title":"Progress of hearing loss in neurofibromatosis type 2: implications for future management","author":"Kontorinis","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.neuchi.2015.10.006_bib0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MAO.0000000000000671","article-title":"Subjective outcomes of auditory brainstem implantation","volume":"36","author":"McSorley","year":"2015","journal-title":"Otol Neurotol"},{"issue":"9","key":"10.1016\/j.neuchi.2015.10.006_bib0115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/MAO.0b013e3182a1a8b4","article-title":"English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2","volume":"34","author":"Tysome","year":"2013","journal-title":"Otol Neurotol"},{"issue":"4","key":"10.1016\/j.neuchi.2015.10.006_bib0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/02688697.2013.771143","article-title":"Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2","volume":"27","author":"Moffat","year":"2013","journal-title":"Br J Neurosurg"},{"issue":"1","key":"10.1016\/j.neuchi.2015.10.006_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MAO.0000000000000185","article-title":"Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2","volume":"35","author":"Lloyd","year":"2014","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.neuchi.2015.10.006_bib0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1399-0004.2011.01816.x","article-title":"Genetic testing and screening of individuals at risk of NF2","volume":"82","author":"Evans","year":"2012","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.neuchi.2015.10.006_bib0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0032-1301396","article-title":"The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2","volume":"73","author":"Hornigold","year":"2012","journal-title":"J Neurol Surg B Skull Base"},{"issue":"10","key":"10.1016\/j.neuchi.2015.10.006_bib0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","article-title":"Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients","volume":"52","author":"Hexter","year":"2015","journal-title":"J Med Genet"}],"container-title":["Neurochirurgie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377015002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377015002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:30:10Z","timestamp":1758436210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028377015002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0028377015002799"],"URL":"https:\/\/doi.org\/10.1016\/j.neuchi.2015.10.006","relation":{},"ISSN":["0028-3770"],"issn-type":[{"value":"0028-3770","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis type 2 service delivery in England","name":"articletitle","label":"Article Title"},{"value":"Neurochirurgie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuchi.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}